Molecular Mechanism for Changes in Proteoglycan Binding on Compositional Changes of the Core and the Surface of Low-Density Lipoprotein-Containing Human Apolipoprotein B100

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 3, 2004, Pages 564-570

  Flood, Christofer ^a   Gustafsson, Maria ^a   Pitas, Robert E ^b,c   Arnaboldi, Lorenzo ^b   Walzem, Rosemary L ^d   Borén, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Apolipoprotein B; Atherosclerosis; Lipoproteins; Phospholipase A2; Proteoglycans; Transgenic mice

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN E; BIGLYCAN; CHOLESTEROL; CHOLESTEROL ESTER; DECORIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE A2; PROTEOGLYCAN; SPHINGOMYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LIPOLYSIS; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; TRANSGENIC MOUSE;

AMINO ACID SUBSTITUTION; ANIMALS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CHOLESTEROL, LDL; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LIONS; LIPOPROTEINS, LDL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHOLIPASES A; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; RECEPTORS, LDL; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SEQUENCE DELETION; SPECIES SPECIFICITY;

EID: 1542343997     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000117174.19078.85     Document Type: Article

References (29)

1. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15:551-561.
2. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417:750-754.
3. Camejo G, Olofsson SO, Lopez F, Carlsson P, Bondjers G. Identification of Apo B-100 segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arteriosclerosis. 1988;8:368-377.
4. Weisgraber KH, Rall SC, Jr. Human apolipoprotein B-100 heparin-binding sites. J Biol Chem. 1987;262:11097-11103.
5. Hirose N, Blankenship DT, Krivanek MA, Jackson RL, Cardin AD. Isolation and characterization of four heparin-binding cyanogen bromide peptides of human plasma apolipoprotein B. Biochemistry. 1987;26:5505-5512.
6. Chan L. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J Biol Chem. 1992;267:25621-25624.
7. Law A, Scott J. A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor. J Lipid Res. 1990;31:1109-1120.
8. Boren J, Olin K, Lee I, Chait A, Wight T, Innerarity T. Identification of the principal proteoglycan binding site in LDL: A single point mutation in apolipoprotein B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest. 1998;101:2658-2664.
9. Olsson U, Camejo G, Hurt-Camejo E, Elfsber K, Wiklund O, Bondjers G. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor. Arterioscler Thromb Vasc Biol. 1997;17:149-155.
10. Kugiyama K, Ota Y, Takazoe K, Moriyama Y, Kawano H, Miyao Y, Sakamoto T, Soejima H, Ogawa H, Doi H, Sugiyama S, Yasue H. Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. Circulation. 1999;100:1280-1284.
11. Kleinman Y, Krul ES, Burnes M, Aronson W, Pfleger B, Schonfeld G. Lipolysis of LDL with phospholipase A2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells. J Lipid Res. 1988;29:729-743.
12. Sartipy P, Camejo G, Svensson L, Hurt-Camejo E. Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans. J Biol Chem. 1999;274:25913-25920.
13. Hurt-Camejo E, Paredes S, Masana L, Camejo G, Sartipy P, Rosengren B, Pedreno J, Vallve JC, Benito P, Wiklund O. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum. 2001;44:2761-2767.
14. Willner EL, Tow B, Buhman KK, Wilson M, Sanan DA, Rudel LL, Farese RV, Jr. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA. 2003;100:1262-1267.
15. Aviram M, Lund-Katz S, Phillips MC, Chait A. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J Biol Chem. 1988;263:16842-16848.
16. Linton MF, Farese RV, Jr., Chiesa G, Grass DS, Chin P, Hammer RE, Hobbs HH, Young SG. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest. 1993;92:3029-3037.
17. Boren J, Lee I, Callow MJ, Rubin EM, Innerarity TL. A simple and efficient method for making site-directed mutants, deletions, and fusions of large DNA such as P1 and BAC clones. Genome Res. 1996;6:1123-1130.
18. Wang X, Chauhan V, Nguyen AT, Schultz J, Davignon J, Young SG, Boren J, Innerarity TL, Rutai H, Milne RW. Immunochemical evidence that human apoB differs when expressed in rodent versus human cells. J Lipid Res. 2003;44:547-553.
19. Boren J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apoB 100. J Clin Invest. 1998;101:1084-1093.
20. Flood C, Gustafsson M, Richardson PE, Harvey SC, Segrest JP, Boren J. Identification of the proteoglycan binding site in apolipoprotein B48. J Biol Chem. 2002;277:32228-32233.
21. Walzem RL, Davis PA, Hansen RJ. Overfeeding increases very low density lipoprotein diameter and causes the appearance of a unique lipoprotein particle in association with failed yolk deposition. J. Lipid Res. 1994;35:1354-1366.
22. Hakala JK, Oomi K, Ala-Korpela M, Kovanen PT. Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin. Arterioscler Thromb Vasc Biol. 1999;19:1276-1283.
23. Grass DS, Felkner RH, Chiang MY, Wallace RE, Nevalainen TJ, Bennett CF, Swanson ME. Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest. 1996;97:2233-2241.
24. Amrine-Madsen H, Koepfli KP, Wayne RK, Springer MS. A new phylogenetic marker, apolipoprotein B, provides compelling evidence for eutherian relationships. Mol Phylogenet Evol. 2003;28:225-240.
25. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem. 1998;273:18250-18259.
26. Yano Y, Shimokawa K, Okada Y, Noma A. Immunolocalization of lipoprotein(a) in wounded tissues. J Histochem Cytochem. 1997;45:559-568.
27. McKeone BJ, Patsch JR, Pownall HJ. Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells. J Clin Invest. 1993;91:1926-1933.
28. Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Ngu'yen TD, Gleeson A, Arad Y, Witte L, Al-Haideri M, Rumsey SC, Deckelbaum RJ. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem. 1994;269:511-519.
29. Coronado-Gray A, van Antwerpen R. The physical state of the LDL core influences the conformation of apolipoprotein B-100 on the lipoprotein surface. FEBS Lett. 2003;533:21-24.